Loading...

bioAffinity Technologies, Inc.

BIAF•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.33
$-0.01(-3.77%)

bioAffinity Technologies, Inc. (BIAF) Company Profile & Overview

Explore bioAffinity Technologies, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

bioAffinity Technologies, Inc. (BIAF) Company Profile & Overview

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMaria Zannes

Contact Information

https://www.bioaffinitytech.com
210 698 5334
22211 West Interstate 10, San Antonio, TX, 78257

Company Facts

57 Employees
IPO DateSep 1, 2022
CountryUS
Actively Trading

Frequently Asked Questions

;